Loading, please wait...This program on Binge Eating Disorder (B. E. D) introduces the pharmacist to a condition recently recognized by DSM5. It is grouped with other eating disorders. There is only one approved drug to treat this disease. That is discussed along with other non-approved drug treatments. Psychotherapy is compared to pharmacotherapy for effectiveness and safety. Specific monitoring parameters are presented for the pharmacist who cares for these patients.
Financial Relationship Disclosure Statement – CPE Consultants, LLC
All individuals involved in the production of this continuing education program including planners, presenters, reviewers, and/or CPE Consultants, LLC staff with an opportunity to control/influence Continuing Education (CE) content to any degree are required to disclose all relevant financial relationships with “ACCME/ACPE – defined” commercial interests. Furthermore, CPE Consultants, LLC requests all such individuals disclose any potential/possible/probable conflict(s) of interest(s) and all conflicts of interest are resolved prior to the CE activity taking place. CPE Consultants, LLC staff or associates will disclose complete financial relationship information prior to the beginning of any CE activity. CPE Consultants, LLC staff, associates and any individual involved in program planning, review and advisory committee members declare no possible or probable conflicts of interest related to this CE activity.
Activity Type
- Knowledge
Accreditation(s)
CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
|
|
|
|
Requirements for CE Credit
After creating your profile, reviewing the PowerPoint presentation and successfully passing (80% or higher) post-test, you can complete the evaluation to claim CPE credit. Complete the evaluation by answering every question. Do not leave any question unanswered. If you do not have a comment or do not feel you want to answer the question, please put “NA” in the space provided. IMPORTANT: You must complete all the above requirements by 30 DAYS FROM PROGRAM. Failure to do so will result in a loss of Continuing Pharmacy Education Credit. A system wipeout clears all pending activity into CPE monitoring during this time, so it is imperative that you complete your evaluations within the allotted time frame. Entering incorrect data will result in a rejection of CPE credit by CPE Monitor. Carefully check your NABP e-Profile ID and date of birth (MMDD) to ensure this data is accurately recorded! If you have any questions regarding how to set up your NABP e-Profile and registering for the CPE Monitor service to ensure your CPE units are properly tracked for licensure, visit: http://www.nabp.net/programs/cpe-monitor/cpe-monitor-service/pharmacists.
This program on Binge Eating Disorder (B. E. D) introduces the pharmacist to a condition recently recognized by DSM5. It is grouped with other eating disorders. There is only one approved drug to treat this disease. That is discussed along with other non-approved drug treatments. Psychotherapy is compared to pharmacotherapy for effectiveness and safety. Specific monitoring parameters are presented for the pharmacist who cares for these patients.
Objectives
- Recognize binge eating disorder from symptoms described for a patient List potential causes of binge eating disorder.
- Describe the effect of binge eating disorder on the overall health of the patient.
- Select and monitor pharmacologic treatment plans for patients with binge eating disorder
- Apply FDA approved treatments for binge eating disorder
Speaker(s)/Author(s)
|
Donald Stansloski |
Activity Number
0864-0000-20-030-H01-P
Release Date:
Jun 11, 2020
Credit Expiration Date:
Jun 11, 2022
